Abstract
Cellulose acetate (CA), viscose, or artificial silk are biocompatible human-benign derivatives of cellulose, one of the most abundant biopolymers on earth. While various optical materials have been developed from CA, optical CA nanomaterials are nonexistent. Here we report on the assembly of a new family of extremely bright fluorescent CA nanoparticles (CA-dots), which are fully suitable for in vivo imaging / targeting applications. CA-dots can encapsulate a variety of molecular fluorophores. Using various commercially available fluorophores, we demonstrate that the fluorescence of CA-dots can be tuned within the entire UV-VIS-NIR spectrum. We also demonstrate excellent specific targeting of tumors in vivo, when injected in blood in zebrafish (xenograft model of human cervical epithelial cancer), and unusually strong ex-vivo topical labeling of colon cancer in mice utilizing CA folate-functionalized nanoparticles.
Introduction
Fluorescent nanoparticles are becoming increasingly popular in biomedical detection and imaging1,2. Compared to molecular fluorophores, fluorescent nanoparticles are typically brighter and more photostable. They can also be functionalized with more than one sensing molecule and utilized for the tagging and tracing of specific molecules, cells, tissues 3–8. Brighter fluorescence facilitates higher signal-to-noise ratio, more sensitive labeling, typically lower limit of detection, etc. The most developed (and commercially available) bright fluorescent nanoparticles are quantum dots (QDs) 9–12. Although excellent in many aspects, they still exhibit a number of problems, including potential toxicity, significant fractions of non-fluorescent QDs, and blinking, etc. 13. Polymer dots 14–17, an organic version of QDs, are promising bright particles which are still under development and have a limited number of available semiconductor polymers. Biodegradation and long-term toxicity of polymer dots have yet to be determined.
Here we report on ultrabright fluorescent nanoparticles (brighter than QDs and sometimes polymer dots of similar spectrum 18) and that are made of one of the most biocompatible, non-toxic and human benign materials, cellulose acetate (CA), viscose, or artificial silk. There is an enormous wealth of knowledge developed during the last century about production, doping, and functionalization of cellulose-based materials on a massive industrial scale. Cellulose acetate has been used in biomedical areas in drug packaging, antimicrobial composites, controlled drug release, wound dressing, bone repairing, and tissue engineering, 19 as a membrane support for various sensors 20,21. Various optical materials have also been developed based on CA 22,23. Any attempts to make fluorescent CA nanoparticles resulted in the particle size of 100–500 nm and larger 24,25. This large size is not suitable for in-vivo applications because such particles are cleared by organisms excessively fast 26. As was shown, an optimum size of particles of 20–90 nm is preferable for such applications 27. In vivo applications of CA nanoparticles are rather attractive because of complete human biocompatibility, low cost, and a wealth of knowledge of CA modification.
In this work, we specifically present the composite assembly of ultrabright fluorescent CA nanoparticles of 50–90 nm in size (CA-dots). Particles become fluorescent through incorporating existing fluorescent dyes into the CA nanoparticle matrix. Besides the simplicity of such synthesis, it allows to cover the entire optical spectrum, from UV-Vis to NIR. We found robust functionalization of the particles with small biomolecules (for example, folates, a ligand targeting the majority of epithelial cancers 28 ) and protective polyethylene glycol (PEG) molecules, the layer needed to decrease nonspecific interactions of the particles with the surrounding in vivo. We establish that such particles are capable of efficient detecting and targeting even small tumors in zebrafish in vivo. Moreover, CA-dots exhibit unusually fast and strong labeling of colon tumors in the mouse colon when applied just topically.
Results and Discussion
Assembly of CA-dots with fluorescent spectra in the entire UV-VIS-NIR range
A modified nanoprecipitation24 approach was employed to manufacture particles in solvents of varying polarity, which facilitated the supramolecular assembly of CA and co-assembled with a guest polymer such as Pluronic F-127, a nonionic, amphiphilic polymer possessing polyethylene glycol (PEG) blocks. In contrast to other nanoprecipitation approaches utilizing cellulose, the described method produces particles of a) smaller sizes, b) high fluorescent brightness that covers the entire spectrum from UV-Vis to NIR, and c) surface functionalization with PEG groups and/or biologically relevant molecules. The use of PEG groups not only allows attaining smaller sizes but also enhances colloidal stability and makes the particles suitable for in vivo applications, an important feature demonstrated in this work.
To functionalize CA-dots, we have developed an facile and modular two-stage one-pot synthesis by first conjugating a biomolecule of interest to the secondary co-assembling polymer, and subsequently, performing the supramolecular assembly step. Polymeric guests participate in the formation of hydrophobic and hydrophilic nanodomains during the supramolecular assembly process. Water drives precipitation of CA dissolved in the organic medium into the aqueous environment; precipitation-catalyzed particle nucleation occurs at the water-organic interface 29,30. Hydrophobic interactions dominate throughout this process, and the flexibility and the amphiphilic nature of the CA backbone enable hydrophobic acetate groups to preferentially assemble towards the core of the particle while hydrophilic hydroxyls remain outward 31. Because polymers and block copolymers like PF127 also possess hydrophilic and hydrophobic moieties, we hypothesized that such polymers will also diffuse into CA-nucleating regions. The formation of a hydrophobic core preferentially concentrates the polymer guest towards the surface, eventually becoming trapped during phase separation25. This results in the desired surface functionalities. Here we demonstrate this approach by functionalizing CA-dots with folate molecules (Fig. 1a, and Fig. 1 of Ref. 32), which made the particles specific to the majority of epithelial cancers 28. Larger molecules, like antibodies can be attached to CA-dots in a more traditional way through, for example, utilizing amine-reactive crosslinker reactive groups like N-hydroxysuccinimide esters (NHS esters) and its derivatives 33.
To demonstrate the ability to assemble particles spanning the entire UV-VIS-NIR fluorescent spectrum, we chose to encapsulate four commercial dyes: Stilbene 420, Rhodamine 560, Tracer Yellow, and Methylene Blue. One can see that the fluorescent spectra of the obtained particles cover the entire spectrum (Fig. 1b,e), with the maximum absorbance ranging from 350 to 665 nm and the maximum emission from 445 to 680 nm (Table 1). Each particle name consists of three parts: CA-Color-Coating molecules (CA stands for cellulose acetate). For example, CA-GREEN-PEG means cellulose acetate with encapsulated Rhodamine 560 (green) dye, coated with PEG molecules. CA- GREEN-PEG-FA means the same particle with additionally added folic acid molecules coating such particles.
Table 1.
CA-dot | Size, Mn (nm) | PDI | Ex/Em (nm/nm) | Brightness (MBTU) / M cm−1 | Brightness relative to QD (times) | Zeta- Potential (mV) | Folates per particle |
---|---|---|---|---|---|---|---|
CA-SB-PEG | 61 | 0.22 | 400/445 | 89 ± 4 / (5.8±0.3) × 106 | 58 1 | −8.0±1 | N/A |
CA-SB-PEG-FA | 50 | 0.17 | 400/445 | 529 ± 42 / (3.4 ±0.3) ×107 | 340 1 | −11±1 | 870±220 |
CAGREEN-PEG | 77 | 0.13 | 495/525 | 870 ± 71 /(6.4 ±0.5) ×107 | 640 2 | −17±2 | N/A |
CA- GREEN - PEG-FA | 68 | 0.14 | 495/525 | 781 ± 49 / (5.8 ±0.4) × 107 | 580 2 | −15±3 | 910±200 |
CA-YEL- PEG | 60 | 0.15 | 450/560 | 159 ± 13 / (4.3±04) × 106 | 43 3 | −3±2 | N/A |
CA- YEL - PEG-FA | 87 | 0.11 | 450/560 | 649 ± 92 / (1.8 ±0.3) × 107 | 180 3 | −7±1 | 1110±180 |
CA- RED/NIR- PEG | 77 | 0.17 | 665/680 | 2554 ± 268 / (1.3 ±0.1) × 108 | 1300 4 | −19±1 | N/A |
CA- RED/NIR - PEG-FA | 63 | 0.20 | 665/680 | 318 ± 38 / (1.6 ±0.2) × 107 | 160 4 | −12±2 | 930±290 |
Physical characteristics of CA-dots
Physical characteristics of CA-dots (Table 1) indicate that we can obtain nanoparticles within the average size of 50–90 nm range (measured with dynamic light scattering, DLS) with good monodispersity (PDI index). The particles size varies with dye and surface functionalization. CA-dots have approximately spherical morphology as seen in the AFM images (Fig. 1c). Accounting for tip convolution, AFM images of single particles had the article diameters similar to the DLS size (for example, 40–50 nm in AFM versus 50–60 nm hydrodynamic size in DLS).
The fluorescent brightness of CA-dots is found (Table 1) using the relative brightness measurements relative to a molecule of the known molecular fluorophore. It is calculated in so-called MESF units (Molecules of Equivalent Soluble Fluorophore; the units used in flow cytometry 11,34–37). We also present these values in terms of another definition of brightness, as a multiplication of the quantum yield ø and the extinction coefficient ε(λ) (M−1 cm−1 units). The latter is a convenient way to compare the brightness of the synthesized CA-dots with other fluorescent particles, for example, quantum dots. One can see that all CA- dots are brighter than quantum dots of similar spectrum. This puts CA-dots in the category of ultrabright fluorescent nanoparticles 18. Notably functionalized water-dispersible QDs have typically smaller diameters of 15–30 nm 38. One might expect that assembling several quantum dots together, one could get nanoparticles of larger size, and expectedly, higher brightness. However, it is impractical because quantum dots quench their fluorescence when the distance between them is less than ~10 nm 13,39. Fig. 1d shows a fluorescent image of individual CA-dots in the vicinity of a glass slide imaged with 100x (1.4N.A.) objective. The different fluorescent intensity of CA-dots can partially be explained by out-of-focus of some particles and particle aggregation on the glass surface.
The particle fluorescence displays much better photostability compared to the free dye (Fig. 1f). As expected, the photostability of dye molecules substantially improves after encapsulation since the polymer matrix limits the availability of oxygen species to initiate bleaching and decreases the thermal motion of dye molecules. For each dye, dramatic improvement in photodegradation resistance is observed after nearly 10 minutes of irradiation. The encapsulated green and yellow dyes, in particular, exhibit essentially zero degradation while their corresponding free dyes diminished in intensity by 8% and 2%, respectively.
The surface coating of CA-dots can be indirectly verified using the Zeta-potential measurements. Native cellulose acetate particles are negatively charged due to the outward orientation of hydroxyl groups produced during self-assembly (Zeta potential is ~30mV in neutral pH). The assembly of CA-dots coated with PEG and PEG-FA noticeably mitigates negative surface potentials of CA-dots (Table 1). It should be noted that still negative overall Zeta potential is important for in vivo applications to avoid fast removal of the particles from blood circulation 40.
To estimate the amount of folate molecules per nanoparticles, we use Raman and absorbance spectroscopy. Decomposing the relative contribution from different constituents of the particles, we can estimate the total amount of folate molecules per particle, Table 1 (see Ref. 32 for detail). It should be noted that it is the estimation of the bulk value of folate molecules, not only those which are located on the surface. Therefore, this estimation should be evaluated as an upper bound estimate for the number of folate molecules on the surface.
CA-dots for IV-injection in vivo
To demonstrate intravenous (IV) application of CA-dots particles in vivo, we utilized human cervical epithelial cancer xenograft model in zebrafish. Since the majority of epithelial cancer cells overexpress folic acid receptors, folate-functionalized CA-dots should preferentially target epithelial tumors within zebrafish. The tumors were initiated through the injection of human cervical epithelial (HeLa) cells near the fish eye (see Fig. 2 of Ref.32). After xenografting, the cancer cells began to spread and create metastases. The fish was immobilized in agarose gel and imaged using a long working distance fluorescent microscope (see Ref.32 for detail). HeLa cells were modified to overexpress RFP (from PDONR221-RFP in lentiviral system) for the ease of identification. We choose CA-SB-PEG-FA nanoparticles which fluorescence in the blue region, which is not overlapping with RFP. This enables straightforward quantification of colocalization of particles with cancer cells, and thus, evaluation of targeting efficiency. CA-SB-PEG particles served as a material control, with the strategy of achieving contrast within tumors by passive diffusion or EPR (Enhanced Permeability and Retention) and not by the active targeting 44.
Very good co-localization between tumors and folate-functionalized CA-dots is observed even after 30 (Fig. 3 of Ref.32). After 50 minutes, it reaches high accuracy of tumor detection (Fig. 2a-c), resulting in a sensitivity (i.e., accuracy of detection of tumor) of 96%, a specificity (i.e, accuracy of detection of absence of tumor) of 96%, and an accuracy (the percentage of correct identification of both tumor and absence of tumor) of 96%. Although we see some nonspecific targeting using control CA-dots (Fig. 2d-f) due to leaky vasculature44 of tumors, much less accumulation of the control particles within tumors was observed (a sensitivity of 65%, a specificity of 80%, and an accuracy of 76% were observed, see Ref.32 for detail). This proves specific folate functionalization of CA-dots as well as their capability the target tumors in vivo.
It is interesting to note that one can clearly identify tumors as small as 10 μm. Since imaging was performed within 30 minutes after injection, the detected size is ~37x smaller and the detection time ~6x faster compared to the previous art (though it was attained on rats: 370 micron and submillimeter-sized tumors were observed after intraperitoneal injection 45,46, respectively). Early detection of small tumors is significant from both applied and fundamental point of use. Clinical outcomes improve and patient mortality significantly decreases when surgeons can recognize and remove submillimeter tumors 47. It is worth noting that the fluorescent images presented in this work were obtained using a long working distance (Olympus MVX-10) stereo microscope, which could directly be used in real surgery. It is definitely interesting to follow the fate of the particles after the observed targeting. This will require long-term study of biodistribution, which we plan to do in future works. It is worth of noting that we do not expect toxicity due to possible biodegradation of cellulose acetate, which is a potential problem for some biodegradable particles, for example made of PLGA 48. Cellulose acetate is not biodegradable at least in human organism 49.
CA-dots for topical tumor targeting ex vivo
Another challenging application for targeting is specific labeling of tumors via topical application of targeting particles. Here we demonstrate targeting ability of folate functionalized CA-dots by using an ex vivo model of colorectal cancer in VillinCreERT2-Apcfl/fl mice. Tumors were studied four weeks status post multiple 4-hydroxy-tamoxifen mucosal injection into the distal colon. After euthanizing, the mouse colon was extracted, gently washed with PBS, and cut with scissors (Fig. 3a,c,f). PBS solution of 0.1 mg/mL of green CA-dots (CA-GREEN-PEG-FA) was introduced on the freshly open colon. After 10 minutes of incubation, the colon was gently rinsed, placed in clear PBS solution and photographed with a long focus fluorescent microscope (Fig. 3b.d,e,f). One can clearly see green fluorescence coming from the locations of tumors, which are easy to identify targeting on brightfield photographs (Fig. 3a,c,f). Normal parts of colon do not show a noticeable targeting (Fig. 3 b,d,f). It is interesting to note rather high heterogeneity of tumor labeling by folate functionalized CA-dots (Fig. 3f). This presumably comes from the heterogeneity of folate receptors on the surface of cancer cells.
To verify if folate functionalized CA-dots are specific to colorectal cancer cells, the targeting was also verified on specially prepared organoids or “mini-intestines” that are deficient in the Apc tumor suppressor gene (similar to cancer studied above). Apc-knockout colon mouse organoids and human colorectal cancer organoids were incubated for 10 minutes at 37°C with folate-conjugated nanoparticles and non-functionalized nanoparticles as the control. Bright-field and fluorescent microscopy pictures were obtained as illustrated by Figure 4. We observed significantly increased fluorescence in organoids incubated in folate-conjugated nanoparticles. Mean fluorescent intensities were calculated and demonstrated a significant difference between both groups (P < 0.0001). This implies that folate-mediated mechanism of specific targeting of colon tumors is a plausible hypothesis of the observed cancer-specific contrast.
Conclusion
We have developed a platform to synthesize novel bright fluorescent nanoparticles using one of the cellulose derivatives, cellulose acetate. The developed approach is modular. It consists of assembly various copolymer – biomolecules of interest (ligand) conjugate, and then using one of those conjugates for supramolecular assembly of CA-dots. Commercial fluorescent dyes can be used without any modifications to create fluorescent properties of CA-dots. Because the fluorescent dye should be initially dissolved in the organic solvent together with cellulose acetate, a broader class of hydrophobic fluorescent dyes can also be used. Further, it is possible to use a physical mix of different dyes within each particle. As a result, a large number of fluorescent spectra can be attained. In principle, the strategy is not limited to encapsulating only fluorescent molecules. Various active (bio)materials can be encapsulated inside CA-dots in a similar manner. It may include different drugs and their combinations for therapeutic and theranostic applications. Excellent targeting of epithelial tumors demonstrated here makes the application of these particles quite promising.
Materials and methods
Materials
30K molecular weight cellulose acetate and Pluronic F127 (PF127) was purchased from Sigma-Aldrich (St. Louis, MO). Dimethylsulfoxide (DMSO) and acetone were purchased from ThermoFisher Scientific (Waltham, MA) and Sigma-Aldrich (St. Louis, MO), respectively. Carboxydiimidazole was purchased from Sigma-Aldrich (St. Louis, MO). 12kD dialysis membranes were obtained from Spectrum Labs (Waltham, MA). 450nm pore size Acrodisc syringe filters were obtained from Pall Corp (Port Washington, NY). The fluorescent dye, Stilbene 420, was obtained from Exciton, Inc. (Dayton, OH).
Synthesis of Supramolecular Cellulose Acetate Nanoparticles
A 1 mg/mL cellulose acetate (CA) solution was prepared 30K MW CA (Sigma-Aldrich) in organic solvent -- DMSO/THF/acetone—(Fisher Scientific, Sigma-Aldrich) via stirring and sonication at room temperature for 3 hours. Separately, a water-soluble guest polymer, PF-127 (Sigma-Aldrich) is stirred into DI water (final polymer concentration of 0.49 mg/mL) over 2 hours. The CA solution is introduced into the aqueous guest polymer solution under high agitation to facilitate nanoparticle assembly. The combined solution was allowed to stir for 12 hours at room temperature. Solvent removal was initiated by placing the mixture under vacuum at 50 C. Trace solvent was removed by dialyzing the nanoparticle solution for 4 days with dialysate changing every 3 hours for the first 2 days (6 hours for nights) and every 12 hours thereafter. Large particulates are removed with a 450 nm pore size syringe filter (Pall Acrodisc).
Synthesis of Control (PEG coated) and Targeted (PEG-Folate) Cellulose Acetate Nanoparticles
A 1 mg/mL cellulose acetate (CA) solution was prepared by dissolving 2 mg of 30K MW CA (Sigma-Aldrich) in a 2 mL of DMSO/acetone (15:85 v/v) mixture (Fisher Scientific, Sigma-Aldrich) via stirring and sonication at room temperature for 3 hours. The dyes were introduced as described in the following example. 1 mg of Stilbene 420 (Exciton, Inc) was dissolved by introducing to the CA solution and stirred at room temperature for 30 minutes. Separately, for targeted particles, 50ul of (concentration 10 mg/mL) PF-127-FA conjugated polymer solution was stirred into DI water (final polymer concentration of 0.49 mg/ml) over 10 minutes. Preparation of Pluronic F127-folic acid conjugated polymer is described in Ref.32). The CA solution with Stilbene 420 is quickly introduced into the PF-127-FA aqueous solution under high agitation to facilitate nanoparticle assembly. For control, PEGylated particles with no targeting ligand, 65 wt% of PF-127 polymer in water was prepared by stirring over 2 hours. The resulting CA solution with Stilbene 420 is introduced into the PF-127 aqueous solution. In both control and targeted CA particle syntheses, the combined organic-aqueous solution was allowed to stir for 12 hours at room temperature. The solvent was removed by placing the mixture under vacuum at 50 C. Trace solvent and free dye were removed by dialyzing the nanoparticle solution for 4 days with dialysate changing every 3 hours (6 hours at night) for the first 2 days and every 12 hours thereafter. Dialysis is complete when no fluorescence of non-encapsulated Stilbene 420 is present in the dialysate. Large particulates are removed with a 450 nm pore size syringe filter (Pall Acrodisc).
Dynamic Light Scattering
Dynamic Light Scattering (DLS) and zeta-potential measurements were conducted in DI water on a Malvern Zetasizer Nano ZS instrument after equilibration at 25C. The intensity-average size (Z-average) and most probable size (mean of number weighted distribution) was the average of three measurements. Typically, DLS uses the laser light of 633 nm and the backscattered light is monitored over light at an angle of 173°. 0.1 mg/mL nanoparticle concentration was used for both size and zeta potential measurements in DI water.
Atomic Force Microscopy
Bioscope Catalyst (Bruker/Veeco, Inc., Santa Barbara, CA) atomic force microscope equipped with a Nanoscope V controller was used in the study. Standard AFM cantilever holders for operation in air were employed. The particles were immobilized on glass slides prepared as follows. Glass slides were placed in an ethanol bath and sonicated for 15 minutes in order to cleanse the surface. Following washing, slides were dried under forced nitrogen gas. Poly-l-Lysine coating was applied to the glass slides via a standard Sigma-Aldrich protocol. In short, the 0.1% w/v poly-l-Lysine solution was diluted 1:10 with deionized water. This working solution was stored in a refrigerator at 2–8° C and allowed to come to room temperature when used. Glass slides were incubated in the poly-l-Lysine solution for 5 minutes, drained and washed with DI water, and dried overnight at room temperature. Then a drop of 0.1 mg/mL solution of nanoparticles was dispensed on the slide and incubated for 60 minutes to allow electrostatic attachment of negatively-charged particles to the positively-charged glass surface. AFM imaging was performed once slides were washed and dried.
Measurements of Fluorescent Properties
Particle fluorescence, brightness, and photostability were measured using the FLUOLOG 3 fluorimeter by Horiba and a UV-VIS Cary 60 spectrophotometer by Agilent. To characterize fluorescent brightness of nanoparticles, we follow the basic definition of the brightness of fluorophores used in flow cytometry, MESF units (Molecules of Equivalent Soluble Fluorophore). This definition is based on the comparison brightness of nanoparticles and a fluorophore of known brightness within the same spectral range (reference fluorophore). Such a definition is independent of a particular spectrometer or methods of measurement. The brightness of a single nanoparticle was calculated using the following formula:
(1) |
where FLNP or FLdye is the fluorescence intensity of a nanoparticle suspension or reference dye solution, respectively. The spectra of both CA nanoparticles and the reference dye solution are very close, so the fluorescence units measured from each sample was evaluated by integrating over the same emission wavelength interval 18,50. The exact intervals and relative brightness obtained in the measurements are shown in Table 1 of Ref.32.
Photostability measurements
Photostability measurements were performed by illuminating 3 mL of fluorescent nanoparticle solutions of the same optical density of 0.01 with white light of 450 W xenon lamp while monitoring intensity with a Horiba Fluorolog 3 (Horiba, Japan) fluorimeter. Optical densities of fluorescent free dye and particles were chosen to have the same 0.01 absorbance. The solutions were separately irradiated continuously using the white light source using a slit width of 14.7 nm. (For comparison, a 1 nm slit width was used when doing standard fluorescence measurements.) Initial fluorescence intensity was recorded at time zero and represents the maximum intensity. Fluorescence was recorded every 60 seconds following continuous exposure and normalized by the maximum intensity to produce a measure of % fluorescence remaining. Photostability measurements were performed for 10 minutes or in the linear kinetic range of photodegradation (up to 80–90% of the initial fluorescence).
In Vivo Imaging of Cellulose Acetate Nanoparticles in Zebrafish
Hela cells overexpressing RFP (from PDONR221-RFP in lentiviral system) were grown up to 70% confluency in DMEM medium with 10% FBS at 37 C and 5% CO2. Hela-RFP cells were harvested using Trypsin, washed 3 times, counted and resuspended in full growth medium at a final concentration of 50.106 cells per mL.
All animals were handled as described in the Boston University School of Medicine zebrafish facility, in accord with our IACUC-approved protocol. AB Zebrafish were bred and normal embryos were raised in the dark up to 2 days post fertilization (dpf). The 2 dpf zebrafish larvae were anesthetized with Tricaine and immobilized for Hela-RFP cells microinjection using sharpened borosilicate glass capillaries (1.0 mm O.D. x 0.78 mm). The Hela-RFP cells micro-injections were all performed by injection of ~1nL directly into the periviteline cavity of the embryo using a micro-injection station. Zebrafish embryos were then incubated for 20 to 28 hours in the dark at 35°C to allow cancer cell spreading to occur.
After Hela-RFP cells widely spread (3 dpf), embryos with evident metastasis were delicately embedded in 3% low melting temperature agarose gel and micro-injected directly behind the eye with ~0.5 nL of 1mg/mL particles CA-dot solutions for time courses and imaged using an Olympus MVX-10 microscope. The measurements of tumor – particle co-localization, calculation of sensitivity, specificity, an accuracy are described in detail in Ref.32.
Mouse colon
Colonic tumors were achieved using a previously described in vivo murine model for colon cancer 51. Briefly, mice with Apcfl/fl-VillinCreER genetic background underwent colonoscopy-guided colonic mucosal injections of 4-hydroxytamoxifen to perform in situ Apc deletion. Two weeks after the injection, colonoscopy of the mice showed tumor formation at the site of injection. Then, the mice were sacrificed, and the colon was dissected and isolated. The colon was cut along its longitudinal axis, was washed gently with cold PBS on ice, and placed on a transparent sterile petri dish. Experiments by application of different nanoparticles were performed under those conditions, and pictures were taken under a fluorescent dissecting microscope.
Colon mouse and human organoids
The colon mouse organoids were prepared and cultured and genetically modified to produced Apc-knockouts by a previously described methods 52,53. Briefly, Apcfl/fl-VillinCreER mice were sacrificed and the colon was dissected and isolated. After incubation in ethylenediaminetetraacetic acid (EDTA), the colonic crypts were scrapped off using a glass slide, collected in PBS, and then spun down. The crypts were mixed with matrigel at an appropriate concentration (i.e. 4–10 crypts/μL), and 50uL of the mixture was plated in the center of a 24-well-plate well. After allowing 10 minutes for matrigel to polymerize at 37°C, 500uL of appropriate culture media consisting of Advanced Dulbecco’s Modified Eagle Medium (ADMEM), Wnt3a, R-spondin, and Noggin, were added to the well. 4-hydroxytamoxifen at a final concentration of 20nM was added to the surrounding media. The organoids were incubated at 37°C and 4% carbon dioxide condition for 2 days and allowed to form organoids. The media was then changed to minimal media that lacks Wnt3a, R-spondin and Noggin, to allow for selection of Apc-knockout organoids.
Acknowledgments
NSF support (grant CBET 1745530) is gratefully acknowledged by I.S. H.F. acknowledges support from NIH (grant CA215059) and the St. Baldrick’s Foundation. F.J.F.L. acknowledges fellowship from Boston University Innovation Center-BUnano Cross-Disciplinary Training in Nanotechnology for Cancer (XTNC).
Footnotes
Competing financial interests
P.B. and I.S. are co-inventors on the US pending patent App. 15/363,077 “Functionalized nanoparticles with encapsulated cargo and method of their self-assembly” filed by NanoScience Solutions, LLC. The other authors declare no competing financial interests.
Data Availability
Data will be made available on request. Some data cannot be shared at this time due to technical or time limitations-the data also form part of an ongoing study.
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
References
- 1.Yang B, et al. , Mater Today (2016) 19 (5), 284 [Google Scholar]
- 2.Shang L, and Nienhaus GU, Mater Today (2013) 16 (3), 58 [Google Scholar]
- 3.Eastman PS, et al. , Nano Letters (2006) 6 (5), 1059. [DOI] [PubMed] [Google Scholar]
- 4.Fritzler MJ, Lupus (2006) 15 (7), 422. [DOI] [PubMed] [Google Scholar]
- 5.Gao XH, and Dave SR, Bio-Applications of Nanoparticles (2007) 620, 57 [Google Scholar]
- 6.Jokerst JV, et al. , Biosens Bioelectron (2009) 24 (12), 3622. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Wang L, and Tan W, Nano Lett (2006) 6 (1), 84. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Wang L, et al. , Bioconjug Chem (2007) 18 (2), 297. [DOI] [PubMed] [Google Scholar]
- 9.Gao J, et al. , Small (2010) 6 (2), 256. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Gao X, et al. , Nat Biotechnol (2004) 22 (8), 969. [DOI] [PubMed] [Google Scholar]
- 11.Medintz IL, et al. , Nature Materials (2005) 4 (6), 435. [DOI] [PubMed] [Google Scholar]
- 12.Bimberg D, and Pohl UW, Mater Today (2011) 14 (9), 388 [Google Scholar]
- 13.Resch-Genger U, et al. , Nature Methods (2008) 9, 763. [DOI] [PubMed] [Google Scholar]
- 14.Chan YH, et al. , Analytical Chemistry (2012) 84 (21), 9431. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Jin YH, et al. , ACS Nano (2011) 5 (2), 1468. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Wu C, et al. , Journal of the American Chemical Society (2010) 132 (43), 15410. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Ye EY, et al. , Mater Today (2014) 17 (4), 194 [Google Scholar]
- 18.Kalaparthi V, et al. , J. Mater. Chem C (2016) 4 (11), 2197 [Google Scholar]
- 19.Bifari EN, et al. , Curr Pharm Des (2016) 22 (20), 3007. [DOI] [PubMed] [Google Scholar]
- 20.Pavinatto FJ, et al. , Biosensors & Bioelectronics (2015) 67, 553. [DOI] [PubMed] [Google Scholar]
- 21.Ng K, et al. , Mater Today (2017) 20 (1), 32 [Google Scholar]
- 22.Anitha S, et al. , Carbohyd Polym (2013) 97 (2), 856. [DOI] [PubMed] [Google Scholar]
- 23.Sacarescu L, et al. , Cellulose (2016) 23 (6), 3847 [Google Scholar]
- 24.Trivedi P, et al. , Cellulose (2016) 23 (3), 1751 [Google Scholar]
- 25.Kulterer MR, et al. , Advanced Functional Materials (2012) 22 (8), 1749 [Google Scholar]
- 26.Jokerst JV, et al. , Nanomedicine (Lond) (2011) 6 (4), 715. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Blanco E, et al. , Nat Biotechnol (2015) 33 (9), 941. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Leamon CP, and Low PS, Proceedings of the National Academy of Sciences of the United States of America (1991) 88 (13), 5572. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Hornig S, and Heinze T, Biomacromolecules (2008) 9 (5), 1487. [DOI] [PubMed] [Google Scholar]
- 30.Fessi H, et al. , Int J Pharm (1989) 55 (1), R1 [Google Scholar]
- 31.Lindman B, et al. , J Mol Liq (2010) 156 (1), 76 [Google Scholar]
- 32.Wu PH, et al. , Nature Methods (2018) 15 (7), 491. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Mattson G, et al. , Mol Biol Rep (1993) 17 (3), 167. [DOI] [PubMed] [Google Scholar]
- 34.Chan WCW, et al. , Current Opinion in Biotechnology (2002) 13 (1), 40. [DOI] [PubMed] [Google Scholar]
- 35.Chan WCW, and Nie SM, Science (1998) 281 (5385), 2016. [DOI] [PubMed] [Google Scholar]
- 36.Lei J, et al. , ACS Nano (2011) 5 (5), 3447. [DOI] [PubMed] [Google Scholar]
- 37.Palantavida S, et al. , J Mater Chem B (2014) 2 (20), 3107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Gao X, et al. , Nat Biotechnol (2004) 22 (8), 969. [DOI] [PubMed] [Google Scholar]
- 39.Dokukin M, et al. , Applied Physics Letters (2009) 95 (17), 173105 [Google Scholar]
- 40.Adams MJ, et al. , Archives of Virology (2015) 160 (7), 1837. [DOI] [PubMed] [Google Scholar]
- 41.Resch-Genger U, et al. , Nature methods (2008) 5 (9), 763. [DOI] [PubMed] [Google Scholar]
- 42.Wu Y, et al. , Analytical Biochemistry (2007) 364 (2), 193. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Chan YH, et al. , Journal of the American Chemical Society (2012) 134 (17), 7309. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Matsumura Y, and Maeda H, Cancer Res (1986) 46 (12 Pt 1), 6387. [PubMed] [Google Scholar]
- 45.Colby AH, et al. , ACS nano (2017) 11 (2), 1466. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Oseledchyk A, et al. , ACS nano (2016) [Google Scholar]
- 47.Colby AH, et al. , Acs Nano (2017) 11 (2), 1466. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Cheng J, et al. , Biomaterials (2007) 28 (5), 869. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Puls J, et al. , J Polym Environ (2011) 19 (1), 152 [Google Scholar]
- 50.Cho EB, et al. , Small (2010) 6 (20), 2314. [DOI] [PubMed] [Google Scholar]
- 51.Roper J, et al. , Nat Protoc (2018) 13 (2), 217. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.O’Rourke KP, et al. , Bio Protoc (2016) 6 (4) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Roper J, et al. , Nat Biotechnol (2017) 35 (6), 569. [DOI] [PMC free article] [PubMed] [Google Scholar]